SUNY VARUGHESE: Open Payments
NPI 1881205169 · SMYRNA, GA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$856 in 47 payments from 17 companies in 2025. Trend: 2023 $516 · 2024 $878 · 2025 $856
Food & beverage: $856
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 10 | $160 |
| Astellas Pharma US Inc | 8 | $154 |
| Lilly USA, LLC | 5 | $83 |
| GlaxoSmithKline, LLC. | 5 | $83 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $72 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $46 |
| Boston Scientific Corporation | 1 | $31 |
| Dynavax Technologies Corporation | 1 | $24 |
| SHIELD THERAPEUTICS INC | 1 | $23 |
Products named: Veozah, Wegovy, JARDIANCE, SHINGRIX, Ozempic, MOUNJARO, XIFAXAN, BREZTRI.
Industry payments across GA — which companies pay providers there.
